Progression of myocardial fibrosis is the major determinant of heart failure hospitalization in patients undergoing transcatheter aortic valve implantation.
30 August 2024 (08:00 - 17:30)
Organised by: 

About the speaker

National Cerebral & Cardiovascular Center, Suita (Japan)
8 More presentations in this session
Doctor K. Hemelrijk (Amsterdam, NL)
Doctor K. Steinhaus (Goettingen, DE)
Doctor C. Garilleti Camara (Santander, ES)
Access the full session
The Event
ESC Congress 2024
30 August - 2 September 2024

